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Abstract
CTLA-4 is an essential inhibitor of T cell immune responses. At steady state, most CTLA-4 resides in intracellular
compartments due to constitutive internalisation mediated via a tyrosine based endocytic motif (YVKM) within the
cytoplasmic domain. This domain is highly conserved in mammals suggesting strong selective pressure. In contrast, the C-
terminal domain varies considerably in non-mammals such as fish, xenopus and birds. We compared the ability of the C-
terminus of these species to direct the trafficking of CTLA-4 with human CTLA-4. Using a chimeric approach, endocytosis
was found to be conserved between human, xenopus and chicken CTLA-4 but was reduced substantially in trout CTLA-4,
which lacks the conserved YXXM motif. Nevertheless, we identified an alternative YXXF motif in trout CTLA-4 that permitted
limited endocytosis. Post-internalisation, CTLA-4 was either recycled or targeted for degradation. Human and chicken CTLA-
4, which contain a YVKM motif, showed efficient recycling compared to xenopus CTLA-4 which contains a less efficient YEKM
motif. Specific mutation of this motif in human CTLA-4 reduced receptor recycling. These findings suggest evolutionary
development in the endocytic and recycling potential of CTLA-4, which may facilitate more refined functions of CTLA-4
within the mammalian immune system.
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Introduction
Within the immune system, ‘‘co-stimulation’’ via the CD28
receptor permits robust and effective CD4+ T cell responses
important for effective immunity. This is mediated by binding to
two ligands CD80 and CD86. Critically, a second receptor,
CTLA-4, also binds these ligands but acts as a negative regulator
of T cell responses, effectively preventing CD28 co-stimulation.
Mice deficient in CTLA-4 die of autoimmune organ destruction
mediated by CD4+ T cells highlighting the essential role of this
pathway in immune regulation [1,2]. Thus the interactions
between CD28, CTLA-4 and their ligands dictate essential
functions during activation of the T cell response. Whilst CD28
is robustly expressed on the T cell surface, CTLA-4 is
constitutively internalised from the plasma membrane and at
steady state, is predominantly located in intracellular compart-
ments raising the question of how intracellular trafficking might
affect the function of CTLA-4.
It is known that CTLA-4 internalisation is mediated by the
interaction of a tyrosine-based endocytic motif located within the
cytoplasmic C-terminus of CTLA-4 [3–6]. This interacts with the
clathrin adaptor AP-2 to mediate clathrin-dependent endocytosis
[3–6]. Following internalisation, CTLA-4 is then either degraded
in lysosomal compartments or recycled back to the plasma
membrane [4,7,8]. We recently proposed that this endocytic
ability may play an important role in CTLA-4 function by
facilitating the capture of its transmembrane co-stimulatory
ligands from opposing cells by a process of transendocytosis [9].
According to this model CTLA-4 is able to regulate the function of
CD28 by depleting antigen presenting cells of ligands thereby
preventing CD28 engagement and signaling. Moreover, this
transendocytosis function of CTLA-4 is seen on both regulatory
T cells and non-specialized T cells that express CTLA-4.
We were therefore interested in the extent to which CTLA-4
intracellular trafficking is conserved during evolution. The CD28/
CTLA-4 co-stimulatory system appears to be present in jawed
vertebrates and CTLA-4 has been identified in teleost fish,
amphibians, birds and mammals [10–12]. Features of the
extracellular ligand-binding site such as M(/L)YPPPY motif
appear to be well conserved across species. In contrast, whilst
the cytoplasmic domain shows a striking degree of conservation in
mammals it is much less well conserved in non-mammals. In this
study we have investigated the ability of different CTLA-4 C-
termini from non-mammals to direct intracellular trafficking using
chimeric proteins composed of the human CTLA-4 ectodomain
fused with the cytoplasmic tail of chicken, xenopus or trout. Our
results reveal considerable variation in CTLA-4 internalisation
kinetics and recycling between species, which support the concept
that intracellular trafficking has evolved as part of the refinement
of CTLA-4 function.
Results
Comparison of the intracellular distribution of CTLA-4
orthologues
In mammals, there is essentially 100% amino acid sequence
conservation of the CTLA-4 cytoplasmic tail (Figure 1A) [10–
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12]. This supports the view that any protein sorting signals
encoded within this region are likely to be of functional
importance. In contrast, in species such as chicken, xenopus and
trout, there is considerable variation in this region (Figure 1B),
which may provide insights into CTLA-4 trafficking and the
regulation of co-stimulation. We therefore generated chimeric
versions of human CTLA-4 where the C-terminus was replaced
with that of chicken, xenopus, or trout CTLA-4 (Figure 1B). We
transfected Chinese hamster ovary (CHO) cell lines with the
CTLA-4 chimeras, labeled the cell surface with wheat germ
agglutinin (WGA) at 4uC and then stained cells for total CTLA-4
expression using an antibody to the human CTLA-4 ectodomain
to assess localisation (Figure 1C). Xenopus and chicken chimeras
revealed a pattern similar to human CTLA-4 with a punctate
intracellular distribution. In contrast, the chimera with the trout
C-terminus showed robust surface expression with far more
limited intracellular vesicles. This difference in the amount of
surface CTLA-4 relative to the total was quantified by flow
cytometry and is shown in figure 1D.
Comparison of the endocytic ability of CTLA-4
orthologues
The increased surface expression observed with chimeric trout
CTLA-4 suggested that the C-terminus of trout CTLA-4 might
confer less efficient internalisation consistent with its lack of a
YXKM motif. To assay internalisation directly, we labeled cells at
37uC with an unconjugated anti-CTLA-4 Ab so as to label CTLA-
4 protein cycling from the plasma membrane. Cells were
subsequently placed on ice to prevent further trafficking and
receptors remaining at the cell surface labeled with a fluorescently
conjugated secondary antibody (red). Cells were then fixed and
permeabilised and internalised CTLA-4 protein detected with a
different fluorescently conjugated secondary antibody (green)
before analysing cells by confocal microscopy (Figure 2A). To
quantify these differences, internalisation was also measured as a
ratio of plasma membrane (red) to internalised (green) CTLA-4
(Figure 2B). Human CTLA-4 possessed the lowest surface to
internalised ratio reflecting that CTLA-4 is predominantly
localised in intracellular vesicles, which was similar to chimeric
constructs from xenopus and chicken CTLA-4. In contrast, the C-
terminus of trout CTLA-4 showed a greater surface to internalised
ratio suggesting relatively poor endocytosis consistent with its more
obvious surface phenotype.
To assay the efficiency of CTLA-4 internalisation more
quantitatively in multiple cells, we used a flow cytometric
approach. Cycling CTLA-4 was labeled with a PE-conjugated
anti-CTLA-4 Ab at 37uC. Cells were subsequently washed and
placed on ice and any residual surface primary antibody was
detected using a secondary antibody (Figure 2C). For WT
CTLA-4 this generates a curved plot where the extensive cycling
label at 37uC (Y-axis) is greater than the minimal surface label (x-
axis), typical of an endocytic protein. Whilst both chicken and
Figure 1. Generation and localisation of CTLA-4 chimeras. A. C-
terminal sequence alignments of selected mammalian CTLA-4 based on
sequence data from Ensembl and in ref 12. B. Diagram of human CTLA-
4 chimeras containing the extracellular and transmembrane domain of
human CTLA-4 and the C-terminus of species shown. C-terminal amino
acid sequence alignments of human, chicken, xenopus and trout CTLA-4
are shown below, based on alignments using Clustal W. C. CHO cells
expressing CTLA-4 chimeras were incubated with WGA-tetramethylr-
hodamine at 4uC for 45minutes. Cells were subsequently fixed,
permeabilised, and stained with an unlabeled anti-CTLA-4 Ab followed
by Alexa488 anti-human IgG (green) to stain total CTLA-4 protein. Cells
were analysed by confocal microscopy. D Relative expression of surface
(4uC) and total CTLA-4 for each chimera as determined by flow
cytometry.
doi:10.1371/journal.pone.0060903.g001
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xenopus CTLA-4 chimeras showed a similar pattern to human the
chimeric trout CTLA-4 displayed an almost linear relationship
between cycling and surface CTLA-4 (Figure 2D) typical of a cell
surface protein, again suggesting impaired CTLA-4 endocytosis in
trout.
To directly measure the rates of endocytosis we stained the cell
surface pool of CTLA-4 on ice with an unconjugated antibody.
Cells were then warmed to 37uC for the indicated time-points to
allow any internalisation of surface CTLA-4 to take place. Cells
were then placed on ice, and any CTLA-4 remaining at the cell
surface detected with an Alexa647 conjugated secondary antibody.
Accordingly, in this assay the loss of Alexa647 staining over time
reflects endocytosis of CTLA-4. Using this assay, human CTLA-4
showed a comparable rate of endocytosis to the chimeric xenopus
and chicken constructs (Figure 3A), internalising 50% or more
within 5 minutes. In contrast, chimeric trout CTLA-4 showed a
much slower rate of endocytosis taking at least 30 minutes to
achieve 50% internalisation. Nevertheless, chimeric trout CTLA-4
did internalise compared to a control CTLA-4 chimera with a
cytoplasmic domain from CD86, which is a plasma membrane
resident in CHO cells (Figure 3A). However, it was clear that
even for surface proteins (CTLA-4-CD86) there was a small
decrease in signal over time in this assay, which was not due to
endocytosis, further emphasising the much reduced endocytic
nature of the trout chimera.
Since internalisation of CTLA-4 occurs via an AP-2 mediated,
clathrin-dependent pathway [3,5,6], treatment with hypertonic
sucrose can be used to inhibit the formation of clathrin-coated
vesicles [13]. We therefore tested the effect of sucrose treatment on
human CTLA-4 and the chimeric constructs. As shown in
figure 3B sucrose treatment inhibited the endocytosis of
CTLA-4 molecules. In particular the more rapid endocytosis seen
in chicken, xenopus and human CTLA-4 chimeras (relative to trout)
was prevented by sucrose treatment. Overall, this data suggests
that the chimeras internalise via a clathrin dependent pathway.
The transferrin receptor is well characterized and internalizes
by clathrin-dependent endocytosis using signals encoded in the
cytoplasmic tail [14]. Using transferrin as a marker for the clathrin
pathway, we compared the co-localisation of the CTLA-4
chimeras with transferrin. Cells were incubated with transferrin
AlexaFluor633 and anti-CTLA-4 PE at 37uC for 45 minutes and
subsequently fixed and analysed by confocal microscopy. This
revealed that human, chicken and xenopus CTLA-4 co-localised
with transferrin in intracellular vesicles, suggesting CTLA-4
internalisation overlaps with the transferrin receptor consistent
with both proteins utilizing the clathrin-dependent pathway
(Figure 3C). Additionally, this assay revealed limited but
detectable co-localisation between trout CTLA-4 and transferrin,
further suggesting that trout CTLA-4 does internalise via clathrin
albeit at a reduced rate.
Whilst trout CTLA-4 lacked the conserved YVKM internalisa-
tion motif found in mammals, it did appear to have a putative
YxxF motif [12], which could possibly mediate endocytosis. We
therefore tested whether this motif contributed to the internalisa-
tion observed with the chimeric trout CTLA-4. We mutated this
tyrosine residue to a valine and examined the behaviour of this
mutant in CHO cells. A comparison of internalisation rates
indicated the VGNF mutant had further impaired endocytosis
compared to the YGNF control and now resembled the behavior
of non-endocytic proteins seen above using sucrose or with the
surface CD86 chimera (Figure 3D). In contrast to chimeric trout
CTLA-4 containing YGNF, the VGNF mutant demonstrated no
co-localisation with transferrin (Figure 3E). Together, these
results confirmed the presence of a functional tyrosine-based
Figure 2. Cellular localisation of CTLA-4 chimeras. A. CHO cells
expressing CTLA-4 chimeras were incubated with unlabeled anti-CTLA-4
Ab at 37uC for 1 hour, cooled to 4uC and surface CTLA-4 stained red
with anti-mouse Alexa 555. Cells were subsequently fixed, permeabi-
lised and stained with Alexa488 anti-mouse IgG (green) and imaged by
confocal microscopy. B. The ratio of plasma membrane to internalised
CTLA-4 fluorescence (PM/I) was calculated by outlining cells in ImageJ.
C. CHO cells expressing human CTLA-4 were labeled with anti-CTLA-4
PE at 37uC for 30 minutes followed by labeling surface CTLA-4 on ice
(4uC) with Alexa647 anti-mouse IgG. Cells were analysed by flow
cytometry and data are plotted as cycling CTLA-4 (37uC label) vs surface
CTLA-4 (4uC label). D. CHO cells expressing the CTLA-4 chimeras were
labeled as described in C and analysed by flow cytometry. Dotted line
provides a standard gradient for reference purposes.
doi:10.1371/journal.pone.0060903.g002
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endocytic motif in trout CTLA-4 albeit one that functions with
reduced efficiency.
Degradation of CTLA-4 orthologues correlates with
endocytic ability
CTLA-4 has previously been reported to interact with the
lysosomal sorting adaptor AP-1 and to undergo degradation in
lysosomal compartments [8,15]. We therefore compared the
stability of our CTLA-4 chimeras by blocking new protein
synthesis using cycloheximide (CHX) and monitoring the decay
of existing CTLA-4. In addition, if CTLA-4 was being degraded
via a lysosomal pathway then ammonium chloride (NH4Cl) should
prevent degradation. We therefore monitored CTLA-4 protein
stability in the presence of CHX or NH4Cl for 3 hours at 37uC.
After treatment, cells were fixed and permeabilised prior to
staining to reveal total CTLA-4 expression and analysed by
confocal microscopy or flow cytometry. In the absence of new
protein synthesis, rapid loss of human, chicken and xenopus CTLA-
4 was observed (Figure 4A) indicating that CTLA-4 was
degraded rapidly. Degradation was quantified by both confocal
analysis (Fig. 4B –left column) and by flow cytometry (Fig. 4B
–right column). Moreover, NH4Cl resulted in an accumulation
of CTLA-4 (predominantly in human, xenopus and chicken
chimeras) suggesting that blocking lysosomal function prevents
CTLA-4 degradation (Figure 4B). Whilst human CTLA-4,
chimeric xenopus and chicken showed comparable degradation, the
trout CTLA-4 chimera was much less affected by CHX although
compared to the non-endocytic variants (trout VGNF and CTLA-
4-CD86 chimera) some degradation was still evident (Figure 4B).
To determine if CTLA-4 co-localised with markers of
lysosomes, the CTLA-4 chimeras were also transfected with the
lysosomal membrane protein CD63, fused to GFP, in the presence
of NH4Cl. Notably, human, chicken and xenopus CTLA-4 all
demonstrated substantial co-localisation with CD63-GFP, suggest-
ing traffic to lysosomal compartments (Figure 4C). In contrast,
the non endocytic trout VGNF mutant and the cell surface CTLA-
4-CD86 chimera demonstrated no obvious co-localisation with
CD63. Collectively these data suggest that degradation of CTLA-4
is related to its endocytic capacity and that the presence of YV/
EKM motif promotes both internalisation and sensitivity to
lysosomal degradation. Moreover, trout CTLA-4 contains an
alternate tyrosine-based motif that has a reduced efficiency of
endocytosis and has a more stable cell surface phenotype when
compared to CTLA-4 from human, chicken and xenopus.
Differing ability to recycle amongst CTLA-4 orthologues
We have recently shown that once internalised a proportion of
CTLA-4 molecules can recycle back to the plasma membrane [4].
Since variation in endocytic motifs may also affect recycling [16],
we assessed this property in our chimeras. To assay CTLA-4
recycling, cells were incubated at 37uC with a PE-conjugated anti-
CTLA-4 Ab for 30 minutes to label the cycling pool of CTLA-4.
Cells were then incubated further at 37uC for various times with
an Alexa647 antibody to label any of the primary antibody
recycling back to the cell surface. Accordingly, recycling CTLA-4
is seen as an increase in the Alexa647 signal over time. Notably,
human CTLA-4 and chimeric chicken CTLA-4 (YVKM contain-
ing proteins) showed a comparable rate of recycling (Figure 5A
and B) whereas chimeric xenopus and trout CTLA-4, which lacked
YVKM motif were notably less efficient.
Since an acidic residue (E) at the +1 position of YxxM has been
suggested to favour an interaction with the lysosomal sorting
adaptor AP-3 [17], we mutated the YVKM motif in human
CTLA-4 to YEKM and assayed the efficiency of internalisation
and recycling. The CTLA-4 YEKM construct remained endocytic
albeit with slightly reduced efficiency compared to CTLA-4
YVKM (Figure 6A). However, we also observed impaired
recycling by CTLA-4 YEKM (Figure 6B), which was reminis-
cent of the lower recycling observed for the xenopus CTLA-4
chimera (Figure 6C). Taken together these data suggest that the
YVKM motif found in mammalian CTLA-4 is optimised for both
endocytosis and recycling of CTLA-4 and that even relatively
subtle variations as found in xenopus CTLA-4 can compromise
these functions.
Discussion
The role of intracellular trafficking in CTLA-4 function is not
well understood, however the high degree of cytoplasmic domain
sequence conservation in mammals is intriguing. CTLA-4-
expressing T cells play an essential role in immune regulation
where CTLA-4 is required in order to prevent T cell responses to
host tissues. This is achieved by expression of CTLA-4 on
specialised regulatory T cells [18]. We have recently shown that a
core feature of CTLA-4 biology is its ability to capture ligands
from opposing cells, internalise them in a process termed
transendocytosis [9]. Such a function presumably involves the
specialised intracellular trafficking itinerary. Indeed it is clear that
ligands captured by transendocytosis are degraded in the
lysosomes in the CTLA-4 expressing cells [9]. Here we have
analysed the impact of naturally occurring C-terminal sequence
variations of CTLA-4 (found in non-mammals) for their impact on
trafficking.
We show that C-terminal amino acid sequence variation has an
impact on CTLA-4 endocytosis, recycling and degradation. Whilst
in general CTLA-4 shows the ability to internalise in all the
chimeras tested, we noted that the C-terminus of trout CTLA-4
conferred a substantially reduced efficiency and consequently a
much higher plasma membrane expression at steady state.
Nonetheless endocytosis could occur through a newly identified
YGNF motif. Interestingly this YxxF motif is found in several fish
species including trout and salmon. Moreover, in zebrafish a
YVKF motif is observed which is remarkably similar to the
YVKM found in mammalian CTLA-4 [12]. Whilst there are a
number of fish genomes undergoing analysis, at present the
unequivocal identification of CD28 and CTLA-4 genes is still
limited and therefore awaits further characterization. Thus it is
plausible that these motifs represent the initial, albeit rather
ineffective, emergence of endocytosis in CTLA-4. In contrast to
fish, the C-terminus of amphibian (Xenopus) and chicken (Gallus
gallus) CTLA-4 both conferred strong endocytic ability that was
Figure 3. Endocytosis rates of CTLA-4 chimeras. A. CHO cells expressing CTLA-4 chimeras were labeled at 4uC with anti-CTLA-4 to label surface
CTLA-4. Cells were then warmed to 37uC to allow endocytosis for the times indicated. Cells were then placed on ice and any remaining surface CTLA-
4 detected with Alexa647 anti-mouse IgG. The 647 signal was plotted against time as the fraction remaining compared to 4uC. B. CHO cells
expressing CTLA-4 chimeras were labeled as in A but in medium supplemented with sucrose (0.45 M) to prevent endocytosis. C. CHO cells expressing
the chimeric CTLA-4 constructs were incubated with a transferrin (Tf) Alexa633 conjugate (Invitrogen) and anti-CTLA-4 PE at 37uC for 45 minutes. Cells
were subsequently fixed and analysed by confocal microscopy. The red arrows indicate co-localisation. D. Rate of endocytosis of VGNF mutant was
performed as described in A. E. Transferrin uptake of VGNF mutant was performed as described in C and analysed by confocal microscopy.
doi:10.1371/journal.pone.0060903.g003
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more similar to that of human CTLA-4. This endocytic ability was
also well correlated with the susceptibility of CTLA-4 to
degradation suggesting endocytosis exposes CTLA-4 to degrada-
tion in lysosomes. We also observed some differences in recycling
ability of CTLA-4 between various species. In particular,
differences between human and xenopus CTLA-4 appeared to
relate to the use of the less efficient YEKM by xenopus. Taken
together our data show that CTLA-4 C-terminal domain directs a
relatively complex intracellular trafficking itinerary, which is to a
large extent seen in amphibians and birds, albeit with some
Figure 4. Degradation of CTLA-4 chimeras. A. CHO cells expressing CTLA-4 chimeras were incubated in medium or medium supplemented with
cycloheximide (CHX) at 37uC for 3 hours. Cells were fixed, permeabilised and stained for total CTLA-4 with an unlabeled anti-CTLA-4 Ab followed by
Alexa488 anti-mouse IgG (green) and nuclei counterstained using DAPI (blue). Cells were analysed by confocal microscopy. B Total CTLA-4 was
quantified by outlining cells in ImageJ and MFI plotted (left column). For flow cytometric quantitation (right hand column) cells were stained for total
CTLA-4 using anti-CTLA-4 PE after 3 hours of CHX or NH4Cl treatment at 37uC and MFI plotted as a percentage of initial fluorescence. C. CHO cells
expressing CTLA-4 chimeras were transfected with CD63-GFP. Cells were incubated in medium supplemented with NH4Cl at 37uC for 3 hours. Cells
were fixed, permeabilised, and stained with an unlabeled anti-CTLA-4 Ab and Alexa565 anti-human IgG (red) to stain total CTLA-4 protein and
analysed by confocal microscopy. The red arrows indicate co-localisation.
doi:10.1371/journal.pone.0060903.g004
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variation. In contrast, these features are much less well developed
in fish suggesting that CTLA-4 function may have evolved via
mutation and selection of cytoplasmic domain variants.
It is interesting to speculate on the impact of these changes in
trafficking on CTLA-4 function. It is known that the major
innovations that have taken place in vertebrate immune systems
relate to the development of lymph nodes [19] and more
specialised immune features such as T cell memory enhanced
effector function. These features are found in mammals and birds
but not in fish. Interestingly, such advanced immune features have
also given rise to the requirement for a subset of specialised
regulatory T cells which prevent immune damage to self tissues
possibly required to regulate these enhanced effector functions
[20]. It is interesting to note that CTLA-4 is utilized as a major
effector molecule expressed by regulatory T cells [2]. Thus one
might tentatively suggest that in order to operate in a cell-extrinsic
manner (required by regulatory T cells) CTLA-4 [18]internaliza-
tion and intracellular trafficking may have been adapted in order
Figure 5. Recycling rates of CTLA-4 chimeras. A. CHO cells expressing WT human CTLA-4 were labeled with mouse anti-CTLA-4 PE at 37uC to
detect cycling CTLA-4, washed and any recycling CTLA-4-PE antibody detected by addition of Alexa647 anti-mouse IgG at either 4uC or 37uC.
Representative FACS plots are shown for PE-label (cycling CTLA-4) vs Alexa647 label (re-cycling CTLA-4) at the indicated time points. B. Recycling
rates are plotted for the chimeras as normalised to the 4uC control.
doi:10.1371/journal.pone.0060903.g005
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to facilitate efficient ligand removal and disposal from antigen
presenting cells. In contrast, in species without the need for such
specialised regulation, CTLA-4 may have been able to perform
useful functions by competing for ligand binding whilst remaining
predominantly at the cell surface as seen in fish CTLA-4.
Materials and Methods
DNA constructs and transfectants
Full-length CTLA-4 cDNA was cloned into a CMV expression
vector pcDNA3.1 as previously described [21]. Chimeric proteins
of human CTLA-4 with the cytoplasmic tail of chicken, xenopus
or trout were synthesised by Genscript and cloned into the same
vector. Point mutation of CTLA-4 YEKM and Human Trout
VGNF CTLA-4 chimera were generated using the QuikChange
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies).
Cell culture and tissue culture
Chinese hamster ovary (CHO) cells were cultured in DMEM
medium supplemented with 2 mM L-glutamine, 10% FBS, 1%
penicillin and streptomycin in a humidified 37uC/5% CO2
incubator and passaged by trypsinisation. CHO cell lines
expressing different cDNA constructs were generated by electro-
poration (AMAXA). Cells expressing the CTLA-4 chimeras were
selected using G418 (500 mg/ml) treatment and by cell sorting.
Confocal microscopy
Imaging was carried out using a Zeiss Axiovert LSM510
confocal microscope and Zeiss LSM 780 inverted laser scanning
confocal microscope using a 100X oil-immersion objective with
excitation at 488 nm, 543 nm and 633 nm. Constant laser powers
and acquisition parameters were maintained throughout individ-
ual experiments for analysis. For quantitation, cells were outlined
and mean fluorescence intensity (MFI) measured using ImageJ
(Wayne Rasband, NIH). All confocal images shown are represen-
tative of at least 40 cells taken from at least three independent
experiments.
For analysis of localisation, CHO cells expressing CTLA-4
chimeras were plated overnight on a poly-L-lysine coated coverslip
in a 24 well plate. For surface expression, cells were incubated with
Wheat Germ Agglutinin (WGA) - tetramethylrhodamine conju-
gate (Molecular Probes, Invitrogen) at 4uC for 45 minutes. Cells
were then washed with 4uC medium and fixed in 3% PFA in PBS
for 15 minutes. Cells were permeabilised with PBS containing
0.1% saponin (PBS/sap) and receptors detected by incubation
with PBS/sap containing unconjugated anti-CTLA-4 Ab and
Alexa488 conjugated anti-human IgG. Following staining, cover-
slips were dried, inverted and mounted with Vectorshield (Vector
Laboratories, UK) prior to visualisation by confocal microscopy.
For analysis of transferrin uptake, CHO cells expressing CTLA-
4 chimeras were incubated at 37uC with Transferrin Alexa-
Fluor633 conjugate (Molecular Probes, Invitrogen) and anti-
CTLA-4 PE at 37uC for 45 minutes. Cells were then washed with
4uC medium and fixed in 3% PFA in PBS.
For analysis of surface vs internalised CTLA-4, CHO cells
expressing CTLA-4 chimeras were incubated at 37uC with
unconjugated anti-CTLA-4 Ab (clone 11G1) for 1 hour. Cells
were then washed 3 times in medium (4uC) and placed on ice.
Surface receptors were labeled on ice by addition of Alexa555
conjugated anti-mouse IgG. Cells were then washed with 4uC
medium and fixed in 100% Methanol at 220uC for 30 minutes.
Internalised receptors were then detected by incubation with PBS
containing Alexa488 conjugated anti-mouse IgG.
For analysis of degradation, cells were incubated in medium
alone or medium supplemented with CHX at 37uC for 3 hours.
Cells were fixed with 3% PFA in PBS and permeabilised with
PBS/sap. Total CTLA-4 was then detected by incubation with
unconjugated anti-CTLA-4 Ab (clone 11G1) and Alexa488
conjugated anti-mouse IgG in PBS/sap.
For analysis of CTLA-4 co-localisation with the lysosomal
pathway, CHO cells expressing CTLA-4 chimeras were transfect-
ed with CD63-GFP and incubated in medium supplemented with
NH4Cl to prevent CTLA-4 degradation. Total CTLA-4 was then
detected by incubation with unconjugated anti-CTLA-4 Ab
followed by Alexa565 conjugated anti-human IgG in PBS/sap.
Flow Cytometric Analysis
Flow cytometry was carried out using a FACScan flow
cytometry (BD Biosciences – Oxford, UK) and acquired using
CellQuest software. Analysis was performed using FlowJo
(TreeStar). Flow cytometric plots are representative of at least
three independent experiments.
For analysis of localisation, cells were incubated with anti-
CTLA-4 PE (BD Biosciences) for 30minutes at 4uC (surface) or
were fixed and permeabilised and stained for total CTLA-4. Cells
were analysed by flow cytometry and MFI plotted.
For analysis of internalisation, cells were incubated in medium
or medium supplemented with 0.45 M Sucrose and labeled with
anti-CTLA-4 PE (BD Biosciences) for 30 minutes at 4uC. Cells
were then placed on ice and washed in 4uC medium or sucrose.
Cells were raised to 37uC for various time points, placed on ice
and were stained for surface CTLA-4 with Alexa647 conjugated
anti-mouse IgG. Cells were then washed in 4uC medium and
analysed by flow cytometry.
For analysis of recycling, cells were incubated with anti-CTLA-4
PE for 30 minutes at 37uC. Cells were then placed on ice and
washed in 4uC medium. Surface CTLA-4 was then labeled by
incubation on ice with Alexa647 conjugated anti-mouse IgG.
Recycling CTLA-4 was labeled by incubation at 37uC with
Alexa647 conjugated anti-mouse IgG for various time points. Cells
were then placed on ice and washed in 4uC medium.
For analysis of degradation, cells were incubated in medium or
medium supplemented with CHX or NH4Cl at 37uC for 3 hours.
Cells were fixed with 3% PFA in PBS and permeabilised with
PBS/sap. Total CTLA-4 was then detected by incubation with
anti-CTLA-4 PE.
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Figure 6. Recycling efficiency is regulated by the YVKM motif. A. CHO cells expressing WT human CTLA-4 YVKM or YEKM motif were labeled
at 4uC with anti-CTLA-4 to label surface CTLA-4. Cells were warmed to 37uC for the time indicated. Cells were then placed on ice and the remaining
surface CTLA-4 detected with Alexa647 anti-mouse IgG and plotted over time. B. CHO cells expressing WT human CTLA-4 YVKM or a point mutant
YEKM motif were labeled with mouse anti-CTLA-4 PE at 37uC to detect cycling CTLA-4. Recycling protein was detected with Alexa647 anti-mouse IgG
at 37uC for the indicated time points. Recycling rates are plotted for the CTLA-4 variants normalised to the 4uC control. C. Representative data
comparing human and xenopus CTLA-4 recycling after 30 minutes is shown.
doi:10.1371/journal.pone.0060903.g006
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